您的位置：首页 > 产品中心 > JIM1
产品价格
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 4078180 | 20μl | 4470 | 2-5天 | 4-6周 | |
| 4078180 | 5μg | 4630 | 2-5天 | 4-6周 | |
| 4078180 | 5μg | 5400 | 2-5天 | 4-6周 | |
| 4078180 | 1 VIAL | 11270 | 2-5天 | 4-6周 |
产品性质
| biological source【生物来源】 | human blood |
| growth mode【生长模式】 | Suspension |
| karyotype【核型】 | Not specified |
| morphology【形态学】 | Small spherical |
| products【产品】 | Not specified |
| receptors【受体】 | Not specified |
| technique(s) | cell culture | mammalian: suitable |
| relevant disease(s)【相关疾病】 | cancer |
| shipped in【运输】 | dry ice |
基本信息
| Cell Line Origin【细胞系来源】 | Human myeloma, cancer |
| Cell Line Description【细胞系描述】 | JIM1 is a myeloma tumour line demonstrating typical plasma cell phenotype (CD38, PCA-1 8A and CD24 positive), deficient in DNA repair. JIM1 was derived from plasma myeloma cells derived from pleural fluid of advanced multiple myeloma patient, homoplastic with JIM3. |
| DNA Profile【DNA图谱分析】 | Not specified |
| Culture Medium【培养基】 | Dexter culture medium, consisting of Fischer′s medium + 20% FCS +10-7 M hydrocortisone sodium succinate. |
| Subculture Routine【传代培养常规】 | Seed at 2-9 x 10 5 cells/cm3 5% CO2; 37 ℃. |
| Other Notes【其他说明】 | Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information. |
产品说明
| Disclaimer【免责声明】 | This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form. |
